New PET scan after liver Y-90 treatment
Part of Cancer clinical trials.
This study tests a new way to scan the liver after Y-90 microsphere treatment. You will have an extra PET/CT scan right after your regular scan to see if it gives better images. The goal is to improve how doctors track the treatment's effect on your liver tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to receive Y-90 microsphere treatment for liver cancer.
- You are between 18 and 85 years old.
- You do not have severe claustrophobia or trouble lying still on your back for up to 45 minutes.
- If you are a woman who could become pregnant, you are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET/CT scan (called 68Ga-NYM096) to see if it can help find different types of cancer. The scan may help doctors get clearer pictures of where cancer is in your body.
This study looks at how well Y90 “radioembolization” treatment delivers radiation and how much radiation reaches your body. If you can safely get extra PET/CT scans and blood tests around your treatment, you may be invited to participate.
This trial tests a special PET scan (18F-FSPG) to help guide therapy for people with liver cancer (HCC) who are planning to receive Y90 radioembolization. The scan may help doctors better plan your treatment.
This study tests a targeted radiation treatment called Y90 for liver tumors that are too large for standard approaches. It aims to see how well the treatment works for people with primary or secondary liver cancers that mainly affect the liver and have at least one tumor bigger than 5 cm.
This study tests a higher dose of radiation delivered directly to liver tumors through small beads. It aims to improve tumor control while keeping side effects manageable for people whose liver cancer is not removable by surgery.
This trial tests a special catheter (TriNav) to deliver radiation directly to liver tumors. It aims to improve targeting and reduce side effects for people with liver cancer that cannot be surgically removed.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.